FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968200013> ?p ?o ?g. }

• W1968200013 endingPage "673" @default.
• W1968200013 startingPage "665" @default.
• W1968200013 abstract "PURPOSE: To determine the maximum tolerated duration of infusions at the fixed gemcitabine dose rate of 10 mg/m2/min and to analyze the pharmacodynamic actions in leukemia blasts during gemcitabine therapy. PATIENTS AND METHODS: The study was conducted in a phase I trial by escalating the duration of gemcitabine infusion at a fixed-dose rate of 10 mg/m2/min. Patients with relapsed or refractory acute myelogenous leukemia (AML) received gemcitabine for 8.0 (n = 3), 10.0 (n = 3), 12.5 (n = 8), 15.5 (n = 3), or 18.0 hours (n = 2). Pharmacokinetic and pharmacodynamic investigations were undertaken in circulating AML blasts. RESULTS: Gemcitabine was infused for up to 18 hours at the fixed-dose rate. Four patients had grade 3 toxicities at longer infusion schedules. One patient had a partial remission; two others had a reduction in blasts and concomitant rise in neutrophils. Gemcitabine triphosphate was detectable in AML cells even at 1 hour after the start of infusion in eight patients. The concentration ranged from 130 to 900 μmol/L at the end of the infusion. Consistently, there was a rapid decline in DNA synthesis, which remained suppressed at 85% to 95% during and for at least 10 hours after the end of the infusion. Compared with levels in cells measured before therapy, at 8 hours after the start of the infusion, there was a decline in the cellular purine deoxynucleotide pools. CONCLUSION: At the fixed-dose rate of 10 mg/m2/min, gemcitabine could be administered for longer than 12 hours without untoward toxicity. The favorable toxicity profile and pharmacokinetic and pharmacodynamic features warrant combination with DNA-damaging agents." @default.
• W1968200013 created "2016-06-24" @default.
• W1968200013 creator A5024454882 @default.
• W1968200013 creator A5036290225 @default.
• W1968200013 creator A5057920623 @default.
• W1968200013 creator A5081607886 @default.
• W1968200013 creator A5082102743 @default.
• W1968200013 date "2002-02-01" @default.
• W1968200013 modified "2023-10-06" @default.
• W1968200013 title "Prolonged Infusion of Gemcitabine: Clinical and Pharmacodynamic Studies During a Phase I Trial in Relapsed Acute Myelogenous Leukemia" @default.
• W1968200013 cites W1484251395 @default.
• W1968200013 cites W1512724730 @default.
• W1968200013 cites W1527742565 @default.
• W1968200013 cites W1529048237 @default.
• W1968200013 cites W1560639845 @default.
• W1968200013 cites W1584870064 @default.
• W1968200013 cites W1604895913 @default.
• W1968200013 cites W1680634601 @default.
• W1968200013 cites W1749229087 @default.
• W1968200013 cites W1771471560 @default.
• W1968200013 cites W1795204252 @default.
• W1968200013 cites W1836246344 @default.
• W1968200013 cites W1857358013 @default.
• W1968200013 cites W1858072261 @default.
• W1968200013 cites W1890647543 @default.
• W1968200013 cites W1908664989 @default.
• W1968200013 cites W1914654455 @default.
• W1968200013 cites W1964573195 @default.
• W1968200013 cites W1968118415 @default.
• W1968200013 cites W1973159565 @default.
• W1968200013 cites W1974091141 @default.
• W1968200013 cites W1993491727 @default.
• W1968200013 cites W1999995381 @default.
• W1968200013 cites W2007640889 @default.
• W1968200013 cites W2012432138 @default.
• W1968200013 cites W2027376738 @default.
• W1968200013 cites W2033599472 @default.
• W1968200013 cites W2054543751 @default.
• W1968200013 cites W2074318459 @default.
• W1968200013 cites W2077627228 @default.
• W1968200013 cites W2089062211 @default.
• W1968200013 cites W2101562875 @default.
• W1968200013 cites W2116405723 @default.
• W1968200013 cites W2124839595 @default.
• W1968200013 cites W2131655102 @default.
• W1968200013 cites W2144599319 @default.
• W1968200013 cites W2149502507 @default.
• W1968200013 cites W2155805287 @default.
• W1968200013 cites W2160850143 @default.
• W1968200013 cites W2166480410 @default.
• W1968200013 cites W2168555194 @default.
• W1968200013 cites W2171446101 @default.
• W1968200013 cites W2189806579 @default.
• W1968200013 cites W2245961990 @default.
• W1968200013 cites W2270490184 @default.
• W1968200013 cites W2312064970 @default.
• W1968200013 cites W231262005 @default.
• W1968200013 cites W2406925708 @default.
• W1968200013 cites W2417474553 @default.
• W1968200013 cites W2418526663 @default.
• W1968200013 cites W2461318160 @default.
• W1968200013 doi "https://doi.org/10.1200/jco.20.3.665" @default.
• W1968200013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11821446" @default.
• W1968200013 hasPublicationYear "2002" @default.
• W1968200013 type Work @default.
• W1968200013 sameAs 1968200013 @default.
• W1968200013 citedByCount "49" @default.
• W1968200013 countsByYear W19682000132012 @default.
• W1968200013 countsByYear W19682000132013 @default.
• W1968200013 countsByYear W19682000132014 @default.
• W1968200013 countsByYear W19682000132015 @default.
• W1968200013 countsByYear W19682000132016 @default.
• W1968200013 countsByYear W19682000132017 @default.
• W1968200013 crossrefType "journal-article" @default.
• W1968200013 hasAuthorship W1968200013A5024454882 @default.
• W1968200013 hasAuthorship W1968200013A5036290225 @default.
• W1968200013 hasAuthorship W1968200013A5057920623 @default.
• W1968200013 hasAuthorship W1968200013A5081607886 @default.
• W1968200013 hasAuthorship W1968200013A5082102743 @default.
• W1968200013 hasConcept C111113717 @default.
• W1968200013 hasConcept C112705442 @default.
• W1968200013 hasConcept C121332964 @default.
• W1968200013 hasConcept C126322002 @default.
• W1968200013 hasConcept C126894567 @default.
• W1968200013 hasConcept C142424586 @default.
• W1968200013 hasConcept C143998085 @default.
• W1968200013 hasConcept C2776694085 @default.
• W1968200013 hasConcept C2776863199 @default.
• W1968200013 hasConcept C2777844706 @default.
• W1968200013 hasConcept C2778041864 @default.
• W1968200013 hasConcept C2778397455 @default.
• W1968200013 hasConcept C2778461978 @default.
• W1968200013 hasConcept C2779384505 @default.
• W1968200013 hasConcept C2780258809 @default.
• W1968200013 hasConcept C31760486 @default.
• W1968200013 hasConcept C71924100 @default.
• W1968200013 hasConcept C87355193 @default.
• W1968200013 hasConcept C90924648 @default.

• next